RIGVIR SE

£ 129.00

€ 149.00

$ 169.00

£ 129.00

Incl. Sales Tax

Premium-Grade Biotechnology

Advanced cancer risk management solution:
✅ Designed for individuals with identifiable increased cancer risk
✅ Supports immune resilience in higher-risk conditions
✅ Additional support alongside anti-cancer therapies
✅ Course-based capsule use
✅ Third-party laboratory tested

Powered by Natural Intelligence

Biologically active food supplement RIGVIR^® SE

Supplement Facts

Serving Size: 1 capsule Servings Per Box: 1 capsule in moisture resistant sachet

Ingredients	Amount Per Capsule	% Daily Value
Whey protein isolate	190 mg	*
Traces of a genetically unmodified and non-pathogenic lyophilized ECHO-7 virus Rigvir	10 mg	†
Vitamin B2 (riboflavin)	5mg	385%

* Daily Value for total fat, saturated fat, total carbohydrates, and sugars is <1% per serving. † Daily Value not established. Other Ingredients: Hydroxypropyl methylcellulose (capsule coating). This product contains milk; does not contain gluten, wheat, yeast or soy. Direction For Use: 1 capsule per month with one glass of water in the morning on an empty stomach. If needed, the dose may be increased based on directions by your healthcare professional. Storage: Keep refrigerated at optimum +4°C (39.2°F). Transport at a temperature up to +25°C (77°F) for up to 5 days. The five-day transportation limit is valid only once. Improper storage conditions will cause product degradation. Warning: Food supplements should not be used as a substitute for a complete and balanced diet. Pregnant and breastfeeding women and children should not use this supplement. This product is not intended to diagnose, treat, cure, or prevent any disease. Do not use if the sachet material is punctured or missing. Keep out of reach and sight of children. Produced: GMP facility in EU. Tested by a Third-party Laboratory. Internationally patented. More about RIGVIR SE – Click here. Note. These statements have not been evaluated by the Food and Drug Administration. Rigvir SE is not intended to diagnose, treat, cure or prevent any disease.

Delivery

Rigvir SE standard deliveries are made to US, EU, and UK (10 USD / 15 EUR / 13 GBP) You can check deliveries to other countries with the “Calculate Shipping” option when placing an order. If there is no possibility of delivery to your country, then deliveries are made according to individual orders, so please contact us using the contact form. Deliveries to customers are made at temperatures up to +25°C (77°F) for up to 5 days. The seven-day transportation limit is valid only once. Delivery to pharmacies, clinics, and distributors is carried out under special temperature conditions to maintain the five-day transportation option. Delivery time is 2 weeks maximum. Buy 3 or more Rigvir SE and get free shipping.

Storage

Keep refrigerated at optimum +4°C (39.2°F).

Improper storage conditions will cause product degradation. Transport at a temperature up to +25°C (77°F) for up to 5 days. The five-day transportation limit is valid only once. Expiration date of Rigvir SE is 12 months. The expiry date will be considered when processing the order. Best before: please see packaging. Stability tests of Rigvir SE have been performed with a temperature and expiration date margin.

Package information

Rigvir SE is packed in a cardboard box and inside there is an aluminum sachet with a capsule inside.

Each package is marked with a special sticker that protects against unauthorized opening and the risks of counterfeiting – Learn more Package size: 95x70x25 mm. Package weight: 20 g

Terms of return

If damage to the Rigvir SE packaging indicating possible unauthorized opening is detected upon delivery, the product will be replaced or the payment refunded within 14 days of receipt.

Is Rigvir SE Right for You?

Rigvir SE may be suitable if you:

Have an increased risk of cancer based on personal or family history
Have elevated tumour markers or AI-based cancer risk assessments
Are over 65 years of age
Have precancerous or chronic conditions associated with increased cancer risk*
Are undergoing anti-cancer therapies and seeking advanced supportive use alongside them
Are taking medications known to increase long-term cancer risk

*Examples of risk-associated conditions may include chronic infections (e.g., human papillomavirus [HPV], Helicobacter pylori), chronic inflammatory conditions (e.g., Crohn’s disease, ulcerative colitis), certain long-term metabolic or immune-related conditions (e.g., diabetes), precancerous findings (e.g., polyps, mycoplasmosis, toxoplasmosis), and chronic respiratory conditions (e.g., COPD).

How to Use Rigvir SE?

Take one Rigvir SE capsule with a glass of water in the morning on an empty stomach.

Standard use (low-risk profiles): One capsule per month.

As recommended by healthcare professionals, Rigvir SE should be taken for at least three consecutive months within a six-month period — a total of six capsules per year.

For higher-risk profiles: 2–4 capsules per month at the same intervals.

If needed, dosing may be adjusted within structured courses under professional guidance.

In the case of a confirmed cancer diagnosis, consultation with the International Virotherapy Center is recommended. The center has more than 20 years of experience in the clinical use of oncolytic viruses for cancer treatment.

NOTE. Rigvir SE is not intended to diagnose, treat, cure, or prevent any disease.